ID Epi Spring Seminar Series

Each spring, CCDD hosts an annual seminar series, featuring talks from experts on the latest research in infectious disease epidemiology and modeling.

CCDD is pleased to announce…

Seminar Series Spring 2020 Calendar

Seminars will take place on Thursdays from 1:00 – 1:50 PM in Kresge 502 at Harvard T.H. Chan School of Public Health.

All students, faculty, and staff are welcome to attend. For non-Harvard guests wishing to attend, please contact

Couldn’t attend in person? Watch presentation videos here.

January 30: C. Jessica E. Metcalf, Department of Ecology and Evolutionary Biology and the Woodrow Wilson School, Princeton University
Disease in motion in Madagascar

February 6: Sarah Leavitt, MA, Department of Biostatistics at Boston University
Estimating infectious disease parameters for tuberculosis in Massachusetts using a novel method to link cases

February 13: Brooke Nichols, Assistant Professor, Department of Global Health, Boston University School of Public Health
Optimization of laboratory technology for HIV/TB diagnostics in sub-Saharan Africa: an integrated modeling approach

February 20: Lauren Childs, Assistant Professor, Department of Mathematics, Virginia Tech
Modeling the dynamics of Malaria infection

February 27: Benjamin Lopman, Professor, Department of Epidemiology, Rollins School of Public Health, Emory University
Forget flu: how about a universal norovirus vaccine?

March 5th: Phil Arevalo, Ruth L. Kirschstein NRSA Postdoctoral Fellow, Department of Ecology and Evolution, University of Chicago
Microbial diversity and human health: lessons from bacterial genomes and seasonal influenza

April 2nd: Pia Abel-zur Wiesch, Associate Professor of Biology and Lloyd & Dottie Foehr Huck Early Career Chair, Pennsylvania State University
On the interface between chemical kinetics and population biology: How to design drug dosing strategies

April 9th: Sonja Lehtinen, Postdoctoral Research Associate, ETH Zurich
Evolutionary ecology of antibiotic resistance

…more speakers announced soon!


Spring 2019 Calendar


Couldn’t attend in person? Watch presentation videos here.

February 7: Katia Koelle, PhD, Assistant Professor, Department of Biology, Emory University
Evolutionary constraints in influenza and their consequences for viral cooperation and conflict

February 14: Jacob Bor, SD, Assistant Professor, Departments of Global Health and Epidemiology, Boston University School of Public Health
Infectious disease surveillance using routine laboratory data: Building a novel platform for research on South Africa’s HIV and TB epidemics

February 21: Kathleen Neuzil, MD, MPH, FIDSA, FACP, Director, Center for Vaccine Development and Global Health, Director, Division of Geographic Medicine, Professor, Medicine and Pediatrics, University of Maryland School of Medicine
Influenza vaccine research in the international setting: Trials, tribulations and lessons learned

February 28: Rustom Antia, PhD, Professor, Department of Biology, Emory University
Will original antigenic sin hinder the generation of a “universal” influenza vaccine?

March 7: Adam Lauring, MD, PhD, Associate Professor, Division of Infectious Diseases, Department of Microbiology & Immunology, University of Michigan
Influenza virus evolution, getting personal

March 14: Ying Taur, MD, MPH, Assistant Professor, Infectious Diseases, Memorial Sloan Kettering Cancer Center, Department of Medicine, Infectious Diseases Service
Gut microbiome dynamics during bone marrow transplantation: Revelations for the rest of us


March 28: Duncan MacCannell, Chief Science Officer, Office of Advanced Molecular Detection, CDC
Technological innovation in public health: CDC’s advanced molecular detection program

April 4: Robert Woods, MD, PhD, Assistant Professor, University of Michigan Medical School, Division of Infectious Diseases
Inferring hospital transmission and antibiotic resistance evolution of a multi-drug resistant hospital pathogen

April 11: Natalie Dean, PhD, Assistant Professor, Department of Biostatistics, University of Florida
Applying the test negative design to evaluate vaccine effectiveness during outbreaks

April 18: Isabel Rodriguez-Barraquer, MD, PhD, Assistant Professor, Division of HIV, ID and Global Medicine, Department of Medicine, University of California
Characterizing the global emergence of arboviruses

April 25: Matthew Samore, MD, HA and Edna Benning Presidential Professor of Medicine, Director, Informatics, Decision Enhancement and Analytic Science Center VA Salt Lake City Health Care System, Chief, Division of Epidemiology, University of Utah
MRSA and C. difficile: why are infection rates declining in VA and how can we tell which control efforts are working?

May 2: Caroline Colijn, Canada 150 Research Chair, Simon Fraser University
Designing pneumococcal vaccines with ecological modeling and genomic data

May 9: Daniel Larremore, Assistant Professor, Department of Computer Science & BioFrontiers Institute, University of Colorado
Complex networks and P. falciparum: from evolution to epidemiology

May 16: Tim Anderson, Program lead, Disease Intervention and Prevention, Texas Biomedical Research Institute
Drug resistance evolution in malaria: CRISPR, crosses and more!

Spring 2018 Calendar


Couldn’t attend in person? Watch presentation videos here.

February 8: Why biofilm growth can generate fundamentally different dynamics and mechanisms of antimicrobial resistance. Michael Mina, MD, PhD, Clinical Fellow in Pathology, Brigham and Women’s Hospital.

February 15:  Why biofilm growth can generate fundamentally different dynamics and mechanisms of antimicrobial resistance. Vaughn Cooper, PhD, Associate Professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh.

February 22:  The incidence, etiology, and clinical sequelae of diarrheal diseases in African children before and after rotavirus vaccine introduction. Karen Kotloff, MD, Head of the Division of Infectious Disease and Tropical Pediatrics, and Associate Director of Clinical Studies at the Center for Vaccine Development, University of Maryland School of Medicine.

March 1: On the predictability of infectious disease outbreaks. Samuel Scarpino, PhD, Assistant Professor of Marine & Environmental Sciences and Physics, Northeastern University

March 8: What is required to end AIDS as a public health threat by 2030? John Stover, Vice President and founder, Avenir Health


March 22: Friend or Foe?: Immune responses to dengue and Zika Viruses. Eva Harris, PhD, Professor, Division of Infectious Diseases and Vaccinology, and Director of the Center for Global Public Health, University of California, Berkeley, School of Public Health

March 29:  Why has dengue resurged, why does malaria persist, and can these diseases be controlled by CRISPR-based gene drive and other novel tools? John Marshall, PhD, Assistant Professor in Residence, Biostatistics and Epidemiology, University of California, Berkeley, School of Public Health

*Friday, April 6: Forecasting Influenza from Genetic and Counts Data. Julia Palacios, PhD, Assistant Professor of Statistics, and Assistant Professor of Biomedical Data Science, Stanford University

April 12: Transmission of mosquito-borne viruses in Salvador, Brazil: old timers, newcomers and repeat offenders. Uriel Kitron, PhD, Goodrich C. White Professor, Department of Environmental Sciences, Emory University

April 19: The Rise of Poverty-Related Neglected Diseases – The “NTDs”. Peter Hotez, MD, PhD, Professor, Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine; Director, Texas Children’s Hospital Center for Vaccine Development

April 26: Immune driven pathogen evolution. Sunetra Gupta, PhD, Professor of Theoretical Epidemiology, Department of Zoology, University of Oxford

May 3: Building a better public private partnership for biosecurity: lessons from the coalition for epidemic preparedness innovations. Kendall Hoyt, PhD, Assistant Professor, Geisel School of Medicine, Dartmouth University

May 10: Surveilling the gut bacterial pathogen landscape: Insights into multi-drug resistance. Anne-Catrin Uhlemann, MD, PhD, Florence Irving Assistant Professor of Medicine, Division of Infectious Diseases, College of Physicians and Surgeons at Columbia University

May 17: Can household-targeted interventions meaningfully reduce the risk of TB infection and disease risk in high burden contexts? Jon Zelner, PhD, Assistant Professor, Department of Epidemiology, University of Michigan School of Public Health